Biosyent Inc (BIOYF)
7.49
0.00 (0.00%)
USD |
OTCM |
Jul 01, 16:00
Biosyent Total Assets (Quarterly): 29.60M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 29.60M |
| December 31, 2023 | 31.30M |
| September 30, 2023 | 30.45M |
| March 31, 2023 | 28.65M |
| December 31, 2022 | 29.83M |
| September 30, 2022 | 28.53M |
| June 30, 2022 | 29.48M |
| March 31, 2022 | 30.34M |
| December 31, 2021 | 29.15M |
| September 30, 2021 | 29.26M |
| June 30, 2021 | 27.69M |
| March 31, 2021 | 26.34M |
| December 31, 2020 | 26.33M |
| September 30, 2020 | 23.82M |
| June 30, 2020 | 22.37M |
| March 31, 2020 | 21.96M |
| December 31, 2019 | 23.71M |
| September 30, 2019 | 22.68M |
| June 30, 2019 | 21.36M |
| March 31, 2019 | 22.48M |
| December 31, 2018 | 22.90M |
| September 30, 2018 | 22.73M |
| June 30, 2018 | 21.36M |
| March 31, 2018 | 20.08M |
| December 31, 2017 | 19.96M |
| Date | Value |
|---|---|
| September 30, 2017 | 18.51M |
| June 30, 2017 | 16.70M |
| March 31, 2017 | 14.85M |
| December 31, 2016 | 14.28M |
| September 30, 2016 | 13.16M |
| June 30, 2016 | 12.65M |
| March 31, 2016 | 11.29M |
| December 31, 2015 | 10.53M |
| September 30, 2015 | 9.921M |
| June 30, 2015 | 9.612M |
| March 31, 2015 | 8.582M |
| December 31, 2014 | 9.170M |
| September 30, 2014 | 8.227M |
| June 30, 2014 | 7.158M |
| March 31, 2014 | 5.805M |
| December 31, 2013 | 5.721M |
| September 30, 2013 | 5.406M |
| June 30, 2013 | 4.762M |
| March 31, 2013 | 3.903M |
| December 31, 2012 | 3.672M |
| September 30, 2012 | 3.483M |
| June 30, 2012 | 2.563M |
| March 31, 2012 | 2.116M |
| December 31, 2011 | 1.552M |
| September 30, 2011 | 1.679M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.96M
Minimum
Mar 2020
31.30M
Maximum
Dec 2023
27.30M
Average
28.59M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 73.30M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.029M |
| Shareholders Equity (Quarterly) | 25.57M |
| Current Ratio | 7.718 |